Wang Feng

机构：Kunming Medical University, Shanghai East Hospital · ORCID：0000-0002-3284-5046

发表论文 79 篇 · 总被引 562 次 · h-index 10

代表论文

• Camrelizumab Combined with Chemotherapy Followed by Camrelizumab plus Apatinib as First-line Therapy for Advanced Gastric or Gastroesophageal Junction Adenocarcinoma (2021 · Clinical Cancer Research · 被引 119)
• Combination of Blood Routine Examination and T-SPOT.TB Assay for Distinguishing Between Active Tuberculosis and Latent Tuberculosis Infection (2021 · Frontiers in Cellular and Infection Microbiology · 被引 24)
• Latest developments in chronic intestinal pseudo-obstruction (2020 · World Journal of Clinical Cases · 被引 21)
• Capecitabine or Capecitabine Plus Oxaliplatin Versus Fluorouracil Plus Cisplatin in Definitive Concurrent Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma (CRTCOESC): A Multicenter, Randomized, Open-Label, Phase 3 Trial (2024 · Journal of Clinical Oncology · 被引 17)
• The STAT6 inhibitor AS1517499 reduces the risk of asthma in mice with 2,4-dinitrochlorobenzene-induced atopic dermatitis by blocking the STAT6 signaling pathway (2022 · Allergy Asthma and Clinical Immunology · 被引 17)
• Unraveling the prognostic significance of RGS gene family in gastric cancer and the potential implication of RGS4 in regulating tumor-infiltrating fibroblast (2024 · Frontiers in Molecular Biosciences · 被引 6)